Novavax's net loss was $81 million for the quarter ended December 31, compared with a net loss of $178.3 million a year ago.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback